FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrea De Luca

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Simona Di Giambenedetto; Massimiliano Fabbiani; Salvatore Farina; Annalisa Mondi; Rita Murri; Pierluigi Navarra; Letizia Sidella; Enrica Tamburrini; Roberto Cauda; Nicoletta Ciccarelli; Antonella Cingolani; Manuela Colafigli; Alessandro D'Avino; Andrea De Luca
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study).
Andrea De Luca; Simona Di Giambenedetto; David Dunn; Iuri Fanti; Valeria Ghisetti; Rolf Kaiser; Mattia Prosperi; Anders Sönnerborg; Carlo Torti; David A M C van de Vijver; Kristel Van Laethem; Anne-Mieke Vandamme; Maurizio Zazzi; David Asboe; Loveleen Bansi; Ricardo Camacho; Francisco M Codoñer
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.
K Theys; C Torti; Anne-Mieke Vandamme; J Vercauteren; M Zazzi; Ricardo Camacho; Bonaventura Clotet; Andrea De Luca; Z Grossman; E Schülter; Joke Snoeck; A Sönnerborg; D Struck; Ana Abecasis
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrea De Luca (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Simona Di Giambenedetto; Massimiliano Fabbiani; Salvatore Farina; Annalisa Mondi; Rita Murri; Pierluigi Navarra; Letizia Sidella; Enrica Tamburrini; Roberto Cauda; Nicoletta Ciccarelli; Antonella Cingolani; Manuela Colafigli; Alessandro D'Avino; Andrea De Luca
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study).
The Journal of antimicrobial chemotherapy 2013;68(6):1364-72.
2013: Andrea De Luca; Simona Di Giambenedetto; David Dunn; Iuri Fanti; Valeria Ghisetti; Rolf Kaiser; Mattia Prosperi; Anders Sönnerborg; Carlo Torti; David A M C van de Vijver; Kristel Van Laethem; Anne-Mieke Vandamme; Maurizio Zazzi; David Asboe; Loveleen Bansi; Ricardo Camacho; Francisco M Codoñer
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.
The Journal of infectious diseases 2013;207(8):1216-20.
2013: K Theys; C Torti; Anne-Mieke Vandamme; J Vercauteren; M Zazzi; Ricardo Camacho; Bonaventura Clotet; Andrea De Luca; Z Grossman; E Schülter; Joke Snoeck; A Sönnerborg; D Struck; Ana Abecasis
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir.
Antimicrobial agents and chemotherapy 2013;57(2):1053-6.
2013: Jurgen Vercauteren; Maurizio Zazzi; Eric Van Wijngaerden; Anne-Mieke Vandamme; Gertjan Beheydt; Ricardo Camacho; Bonaventura Clotet; Andrea De Luca; Anna Maria Geretti; Zehava Grossman; Stijn Imbrechts; Rolf Kaiser; Pieter Libin; Mattia Prosperi; Jean-Claude Schmit; Anders Sönnerborg; Carlo Torti; Kristel Van Laethem
Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response.
PloS one 2013;8(4):e61436.
2013: Nicoletta Ciccarelli; Manuela Colafigli; Andrea De Luca; Massimiliano Fabbiani; Rita Murri; Maria Caterina Silveri; Enrico Maria Trecarichi; Roberto Cauda; Simona Di Giambenedetto
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia.
Antiviral therapy 2013;18(2):153-60.
2012: Francesco Saladini; Maurizio Zazzi; C Bianco; V Borghi; T Carli; Andrea De Luca; M Di Pietro; G Filice; M R Gismondo; G Meini; Valeria Micheli; Laura Monno; M Pecorari; G Penco; Grazia Punzi
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012;18(10):E428-30.
2012: Andrea De Luca; Andrea Giacometti; Licia Iacoviello; Giacomo Magnani; Vincenzo Vullo; Andrea Antinori; Maria Rosaria Capobianchi; Roberto Cauda; Manuela Colafigli; Alessandro Cozzi-Lepri; Antonella d'Arminio Monforte; Amalia De Curtis; Katleen de Gaetano Donati
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: a longitudinal study.
Journal of acquired immune deficiency syndromes (1999) 2012;60(3):e98-101.
2012: B Rossetti; C Bianco; Andrea De Luca
Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B.
Infection 2012;40(3):347-9.
2012: Marco Franzetti; Alessia Lai; Paola Meraviglia; Valeria Micheli; Alessia Zoncada; Francesco Roberto Simonetti; Paolo Almi; Patrizia Bagnarelli; Giorgio Bozzi; Paola Corsi; Andrea De Luca; Claudia Balotta
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
The Journal of antimicrobial chemotherapy 2012;67(5):1250-3.
2012: Mattia C F Prosperi; Andrea De Luca
Computational models for prediction of response to antiretroviral therapies.
AIDS reviews 2012;14(2):145-53.
2012: ilaria vicenti; Paolo Almi; Cinzia Caudai; Andrea De Luca; Simona Di Giambenedetto; Genny Meini; Francesco Pippi; Andrea Rosi; Barbara Rossetti; Francesco Saladini; Letizia Sidella; Maurizio Zazzi
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy.
The Journal of antimicrobial chemotherapy 2012;67(4):984-7.
2012: Andrea De Luca; Giuseppe Liotta; Sandro Mancinelli; Maria Cristina Marazzi; Abdul Majid Noorjehan; Anna Maria Doro Altan; Ersilia Buonomo; Susanna Ceffa; Barbara Pedruzzi; Mattia Carlo Felice Prosperi; Paola Scarcella; leonardo Palombi
Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
Journal of acquired immune deficiency syndromes (1999) 2012;59(3):236-44.
2012: Andrea De Luca; Simona Di Giambenedetto; Massimiliano Fabbiani; Angela Marzocchetti; Cristina Mussini; Milena Nasi; Marcello Pinti; Laura Bracciale; Roberto Cauda; Alessandro Cozzi-Lepri; Andrea Cossarizza
Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2012;59(2):113-20.
2012: Gaetana Sterrantino; Michele Trotta; Mauro Zaccarelli; Maurizio Zazzi; Stefano Bonora; Vanni Borghi; Paola Corsi; Andrea De Luca; Francesco Leoncini; Paola Meraviglia
Interpretation of genotypic resistance to predict darunavir/ritonavir failure in antiretroviral experienced patients.
Journal of acquired immune deficiency syndromes (1999) 2012;59(2):170-2.
2012: Alessia Lai; Paola Meraviglia; Valeria Micheli; Stefania Paolucci; Francesco R Simonetti; Danilo Tacconi; Maurizio Zazzi; Gianguglielmo Zehender; Alessia Zoncada; Massimo Ciccozzi; Grazia Colao; Paola Corsi; Andrea De Luca; Marco Franzetti; Angela Gonnelli; Paolo Almi; Patrizia Bagnarelli; Claudia Balotta
HIV-1 subtype F1 epidemiological networks among Italian heterosexual males are associated with introduction events from South America.
PloS one 2012;7(8):e42223.
2012: Soo-Yon Rhee; William Towner; Maurizio Zazzi; Jose Luis Blanco; Andrea De Luca; W Jeffrey Fessel; Josep Maria Gatell; Francesca Incardona; Rolf Kaiser; Tommy F Liu; Iñaki Pere; Robert W Shafer
Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes.
AIDS research and therapy 2012;9(1):13.
2011: M Fabbiani; G Fadda; P Navarra; Enzo Ragazzoni; Rosaria Santangelo; L Bracciale; P Cattani; Roberto Cauda; Simona Di Giambenedetto; Andrea De Luca
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure.
Infection 2011;39(6):563-9.
2011: Angela Marzocchetti; Jessica Schwarz; Enrico Trecarichi; Simona Di Giambenedetto; Massimilliano Fabbiani; Massimo Fantoni; Laura Bracciale; Roberto Cauda; Manuela Colafigli; Andrea De Luca
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy.
AIDS research and human retroviruses 2011;27(12):1299-309.
2011: Simona Di Giambenedetto; M Fabbiani; I Fanti; Angela Gonnelli; G Meini; Paola Meraviglia; V Micheli; E Paolini; S Paolucci; G Penco; Mattia Prosperi; Maurizio Zazzi; Bianca Bruzzone; P Castelli; Paola Corsi; Andrea De Luca; Antonio Di Biagio
Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2011;17(9):1352-5.
2011: Mattia Prosperi; Anders Sönnerborg; Carlo Torti; David A M C van de Vijver; Kristel Van Laethem; Maurizio Zazzi; Loveleen Bansi; Ricardo Camacho; Francisco M Codoñer; Andrea De Luca; Simona Di Giambenedetto; Iuri Fanti; Anna Maria Geretti; Rolf Kaiser; Nicola Mackie
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.
The Journal of antimicrobial chemotherapy 2011;66(8):1886-96.
2011: N Ciccarelli; M Fabbiani; Simona Di Giambenedetto; I Fanti; E Baldonero; L Bracciale; E Tamburrini; Roberto Cauda; Andrea De Luca; Maria Caterina Silveri
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.
Neurology 2011;76(16):1403-9.
2011: Massimiliano Fabbiani; Simona Di Giambenedetto; Michela Sali; Salvatore Farina; Paola Sansonetti; Enrica Tamburrini; Lorenzo Zileri Dal Verme; Giovanni Delogu; Andrea De Luca; David Kelvin; Roberto Cauda; Giovanni Fadda
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients.
Vaccine 2011;29(16):2836-9.
2011: Cinzia Dello Russo; Lucia Lisi; Alessia Lofaro; Simona Di Giambenedetto; Bruno Federico; Giordano Madeddu; Marianna Salerno; Maria Stella Mura; Antonella Pirazzoli; Andrea De Luca; Roberto Cauda; Pierluigi Navarra
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR.
Pharmacogenomics 2011;12(4):567-76.
2011: Massimiliano Fabbiani; Laura Bracciale; Maria Doino; Alessandro D'Avino; Angela Marzocchetti; Pierluigi Navarra; Roberto Cauda; Andrea De Luca; Simona Di Giambenedetto
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients.
The Journal of infection 2011;62(4):319-21.
2011: Massimiliano Fabbiani; Laura Bracciale; Maria Doino; Letizia Sidella; Salvatore Farina; Valentina Di Cristo; Roberto Cauda; Andrea De Luca; Simona Di Giambenedetto
Lipid-lowering effect of tenofovir in HIV-infected patients.
The Journal of antimicrobial chemotherapy 2011;66(3):682-3.
2011: Massimiliano Fabbiani; Simona Di Giambenedetto; Enzo Ragazzoni; Gabriella D'Ettorre; Giustino Parruti; Mattia Prosperi; Laura Bracciale; Roberto Cauda; Pierluigi Navarra; Andrea De Luca
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction.
Pharmacological research : the official journal of the Italian Pharmacological Society 2011;63(3):249-53.
2011: Mattia Prosperi; A Cozzi-Lepri; Andrea Antinori; G Cassola; C Torti; M A Ursitti; G P Pellizzer; A Giacometti; A d'Arminio Monforte; Andrea De Luca
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008.
HIV medicine 2011;12(3):174-82.
2011: Andrea De Luca; Simona Di Giambenedetto; Giovanni Di Perri; Nicola Gianotti; Renato Maserati; Valeria Micheli; Pasquale Narciso; Carlo F Perno; Mattia Prosperi; Maria M Santoro; Maurizio Zazzi; Andrea Antinori; Fausto Baldanti
Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score.
Antiviral therapy 2011;16(4):489-97.
2011: Mattia Prosperi; Maurizio Zazzi; Patrizia Bagnarelli; Bianca Bruzzone; Annapaola Callegaro; Andrea De Luca; Antonio Di Biagio; Simona Di Giambenedetto; Massimo Di Pietro; Iuri Fanti; Valeria Ghisetti; Genny Meini; Valeria Micheli; Elisabetta Paolini; Giovanni Penco
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen.
BMC medical informatics and decision making 2011;11():40.
2011: Federica Tordato; Alessandro Cozzi-Lepri; Paola Cicconi; Andrea De Luca; Andrea Antinori; Vincenzo Colangeli; Antonella Castagna; Paola Nasta; N Ladisa; A Giacometti; Antonella d'Arminio Monforte; Andrea Gori
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure.
HIV medicine 2011;12(1):4-13.
2010: Mattia Prosperi; Maurizio Zazzi; Grazia Punzi; Laura Monno; Grazia Colao; Paola Corsi; Simona Di Giambenedetto; Genny Meini; Valeria Ghisetti; Stefano Bonora; Monica Pecorari; Maria Rita Gismondo; Patrizia Bagnarelli; Tiziana Carli; Andrea De Luca
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice.
Journal of medical virology 2010;82(12):1996-2003.
2010: Rita Murri; Antonella Cingolani; Andrea De Luca; Simona Di Giambenedetto; Giuseppe Marasca; Giuseppe De Matteis; Valentina Mazzoccato; Massimiliano Fabbiani; Carmela Pinnetti; Enrica Tamburrini
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy.
Journal of acquired immune deficiency syndromes (1999) 2010;55(3):411-2.
2010: Luana Fianchi; C Colosimo; Andrea De Luca; A Pompucci; P Cattani; Maria Teresa Voso; Luigi Maria Larocca; Giuseppe Leone; Livio Pagano
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy.
Bone marrow transplantation 2010;45(11):1668-70.
2010: Carmela Pinnetti; Silvia Baroncelli; Paola Villani; Massimo Fantoni; Valerio Tozzi; Andrea De Luca; Roberto Cauda; Gianfranco Anzidei; Maria Cusato; Mario Regazzi; Marco Floridia; Enrica Tamburrini
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.
The Journal of antimicrobial chemotherapy 2010;65(9):2050-2.
2010: M Fabbiani; Simona Di Giambenedetto; Enzo Ragazzoni; Manuela Colafigli; Mattia Prosperi; Roberto Cauda; Pierluigi Navarra; Andrea De Luca
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection.
HIV medicine 2010;11(5):326-33.
2010: Mattia C F Prosperi; Andrea De Luca; Simona Di Giambenedetto; Laura Bracciale; Massimiliano Fabbiani; Roberto Cauda; Marco Salemi
The threshold bootstrap clustering: a new approach to find families or transmission clusters within molecular quasispecies.
PloS one 2010;5(10):e13619.
2010: Mattia C F Prosperi; Laura Bracciale; Massimiliano Fabbiani; Simona Di Giambenedetto; Francesca Razzolini; Genny Meini; Manuela Colafigli; Angela Marzocchetti; Roberto Cauda; Maurizio Zazzi; Andrea De Luca
Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.
Retrovirology 2010;7():56.
2010: Carmela Pinnetti; Enrica Tamburrini; Enzo Ragazzoni; Andrea De Luca; Pierluigi Navarra
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1.
Antiviral therapy 2010;15(1):127-9.
2010: Andrea De Luca; Mattia Prosperi; Laura Bracciale
Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options.
Current opinion in HIV and AIDS 2010;5(1):27-37.
2009: L Bracciale; I Fanti; Simona Di Giambenedetto; Manuela Colafigli; Mattia Prosperi; Alessandra Bacarelli; Rosaria Santangelo; P Cattani; Roberto Cauda; Andrea De Luca
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar years: a cohort study.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;46(3):290-4.
2009: Simona Di Giambenedetto; C Torti; Mattia Prosperi; N Manca; Giuseppe Lapadula; G Paraninfo; N Ladisa; Maurizio Zazzi; M Trezzi; Paola Cicconi; P Corsi; P Nasta; Roberto Cauda; Andrea De Luca
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study.
Infection 2009;37(5):438-44.
2009: Maurizio Zazzi; Mattia Prosperi; ilaria vicenti; Simona Di Giambenedetto; Annapaola Callegaro; Bianca Bruzzone; Fausto Baldanti; Angela Gonnelli; Enzo Boeri; Elisabetta Paolini; Stefano Rusconi; Andrea Giacometti; Franco Maggiolo; Stefano Menzo; Andrea De Luca
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.
The Journal of antimicrobial chemotherapy 2009;64(3):616-24.
2009: L Bracciale; Manuela Colafigli; Maurizio Zazzi; P Corsi; P Meraviglia; V Micheli; R Maserati; N Gianotti; G Penco; M Setti; Simona Di Giambenedetto; L Butini; A Vivarelli; M Trezzi; Andrea De Luca
Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
The Journal of antimicrobial chemotherapy 2009;64(3):607-15.
2009: Manuela Colafigli; Simona Di Giambenedetto; L Bracciale; I Fanti; Mattia Prosperi; Roberto Cauda; Andrea De Luca
Long-term follow-up of nevirapine-treated patients in a single-centre cohort.
HIV medicine 2009;10(8):461-9.
2009: Antonella d'Arminio Monforte; Alessandro Cozzi-Lepri; Antonella Castagna; Andrea Antinori; Andrea De Luca; Cristina Mussini; Sergio Lo Caputo; Massimo Arlotti; Giacomo Magnani; Gianpietro Pellizzer; Franco Maggiolo; Massimo Puoti
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(4):612-22.
2009: Massimiliano Fabbiani; Simona Di Giambenedetto; Laura Bracciale; Alessandra Bacarelli; Enzo Ragazzoni; Roberto Cauda; Pierluigi Navarra; Andrea De Luca
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.
The Journal of antimicrobial chemotherapy 2009;64(1):109-17.
2009: Mattia C F Prosperi; Roberto D'Autilia; Francesca Incardona; Andrea De Luca; Maurizio Zazzi; Giovanni Ulivi
Stochastic modelling of genotypic drug-resistance for human immunodeficiency virus towards long-term combination therapy optimization.
Bioinformatics (Oxford, England) 2009;25(8):1040-7.
2009: Mattia Prosperi; Iuri Fanti; Giovanni Ulivi; Alessandro Micarelli; Andrea De Luca; Maurizio Zazzi
Robust supervised and unsupervised statistical learning for HIV type 1 coreceptor usage analysis.
AIDS research and human retroviruses 2009;25(3):305-14.
2009: Laura Bracciale; Simona Di Giambenedetto; Manuela Colafigli; Giuseppe La Torre; Mattia Prosperi; Rosaria Santangelo; Simona Marchetti; Roberto Cauda; Giovanni Fadda; Andrea De Luca
Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1.
AIDS research and human retroviruses 2009;25(3):261-7.
2009: leonardo Palombi; Maria Cristina Marazzi; Giovanni Guidotti; Paola Germano; Ersillia Buonomo; Paola Scarcella; Annamaria Doro Altan; Ines Da Vitoria M Zimba; Massimo Magnano San Lio; Andrea De Luca
Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(1):115-122.
2009: Simona Di Giambenedetto; Maurizio Zazzi; Paola Corsi; Angela Gonnelli; Massimo Di Pietro; Andrea Giacometti; Paolo Almi; Michele Trezzi; Enzo Boeri; Nicola Gianotti; Stefano Menzo; Romana Del Gobbo; Daniela Francisci; Alessandro Nerli; Luisa Galli; Andrea De Luca
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
Antiviral therapy 2009;14(3):359-69.
2009: Laura Bracciale; Rosaria Santangelo; Iuri Fanti; Mattia Prosperi; Manuela Colafigli; Simona Di Giambenedetto; Simona Marchetti; Aldo Di Franco; Roberto Cauda; Andrea De Luca
Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction?
Antiviral therapy 2009;14(1):99-101.
2008: Philip Grant; Eric C Wong; Richard Rode; Robert Shafer; Andrea De Luca; Jeffrey Nadler; Trevor Hawkins; Calvin Cohen; Robert Harrington; Dale Kempf; Andrew R Zolopa
Virologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scores.
Antimicrobial agents and chemotherapy 2008;52(11):4050-6.
2008: Julian H Elliott; Lutgarde Lynen; Alexandra Calmy; Andrea De Luca; Robert W Shafer; Maria Zolfo; Bonaventura Clotet; Sarah Huffam; Charles A B Boucher; David A Cooper; Jonathan M Schapiro
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
AIDS (London, England) 2008;22(16):2053-67.
2008: L Martín-Carbonero; M Puoti; J García-Samaniego; Andrea De Luca; E Losada; G Quinzan; RAFFAELE BRUNO; A Mariño; M González; M Núñez; V Soriano
Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4.
Journal of viral hepatitis 2008;15(10):710-5.
2008: Andrea De Luca; Adriana Ammassari; Patrizio Pezzotti; Paola Cinque; Jacques Gasnault; Juan Berenguer; Simona Di Giambenedetto; Antonella Cingolani; Yassine Taoufik; Pilar Miralles; Christina M Marra; Andrea Antinori
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.
AIDS (London, England) 2008;22(14):1759-67.
2008: F Pippi; L Bracciale; Lucia Stolzuoli; R Giaccherini; EMANUELE MONTOMOLI; C Gentile; S Filetti; Andrea De Luca; C Cellesi
Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
HIV medicine 2008;9(7):519-25.
2008: L Sighinolfi; C Torti; C Zeni; F Ghinelli; F Suter; F Maggiolo; A Antinori; G Antonucci; F Castelnuovo; N Ladisa; M Migliorino; S Novati; Andrea De Luca; S Lo Caputo; G Paraninfo; C Tinelli; G Carosi
Evolution of antiretroviral prescription and response over a period of 8 years: an Italian multicentre observational prospective cohort study.
Infection 2008;36(3):244-9.
2008: Simona Di Giambenedetto; Andrea De Luca; Paola Villani; Alessandra Bacarelli; Enzo Ragazzoni; M Regazzi; Roberto Cauda; Pierluigi Navarra
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure.
HIV medicine 2008;9(4):239-45.
2008: Manuela Colafigli; Simona Di Giambenedetto; L Bracciale; Enrica Tamburrini; Roberto Cauda; Andrea De Luca
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.
HIV medicine 2008;9(3):172-9.
2008: Simona Di Giambenedetto; Manuela Colafigli; C Pinnetti; Alessandra Bacarelli; Antonella Cingolani; Enrica Tamburrini; Roberto Cauda; Andrea De Luca
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure.
AIDS research and human retroviruses 2008;24(2):149-54.
2008: R Cianci; Andrea De Luca; Giovanni Cammarota; R Cauda; F Pandolfi
HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease.
European review for medical and pharmacological sciences 2008;12(1):67-9.
2007: Marco Bongiovanni; Nicola Gianotti; Elisabetta Chiesa; Paola Nasta; Paola Cicconi; Amedeo Capetti; Antonio Di Biagio; A Matti; Valeria Tirelli; P Marconi; Andrea De Luca; Cristina Mussini; Fulvio Gatti; Mauro Zaccarelli; C Abeli; Carlo Torti; Andrea Antinori; Antonella Castagna; Antonella d'Arminio Monforte
Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.
Infection 2007;35(6):451-6.
2007: Andrea De Luca; Simona Di Giambenedetto; Maria Paola Trotta; Manuela Colafigli; Mattia Prosperi; Lidia Ruiz; John Baxter; Philippe Clevenbergh; Roberto Cauda; Carlo Federico Perno; Andrea Antinori
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.
The Journal of infectious diseases 2007;196(11):1645-53.
2007: Marco Bongiovanni; Andrea Gori; Alessandro Cozzi Lepri; Andrea Antinori; Andrea De Luca; Gabriella Pagano; Alessandro Chiodera; Massimo Puoti; Antonella d'Arminio Monforte
Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(5):650-3.
2007: Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; bruno ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; Jose M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
A whole-genome association study of major determinants for host control of HIV-1.
Science (New York, N.Y.) 2007;317(5840):944-7.
2007: Angela Marzocchetti; maurizio Sanguinetti; Simona Di Giambenedetto; Antonella Cingolani; Giovanni Fadda; Roberto Cauda; Andrea De Luca
Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.
Journal of neurovirology 2007;13(4):338-46.
2007: Andrea De Luca; Jodi Weidler; Simona Di Giambenedetto; Eoin Coakley; Antonella Cingolani; Michael Bates; Yolanda Lie; Rick Pesano; Roberto Cauda; Jonathan M Schapiro
Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):411-7.
2007: Massimo Ciccozzi; Stefania Montieri; Marco Salemi; Tulio De Oliveira; Maria Dorrucci; Alessandro Sinicco; Andrea De Luca; Massimo Giuliani; Claudia Balotta; Giovanni Rezza
An outbreak of HIV-1 subtype G among Italian injecting drug users.
AIDS (London, England) 2007;21(9):1213-5.
2007: Andrea De Luca
Resistance to newly approved and investigational protease inhibitors.
Current opinion in HIV and AIDS 2007;2(2):130-6.
2007: Andrea Antinori; Maria Paola Trotta; Patrizia Lorenzini; Carlo Torti; Nicola Gianotti; Franco Maggiolo; Francesca Ceccherini-Silberstein; Paola Nasto; Antonella Castagna; Andrea De Luca; Cristina Mussini; Massimo Andreoni; Carlo Federico Perno
Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation.
Antiviral therapy 2007;12(8):1175-83.
2007: Simona Di Giambenedetto; Laura Bracciale; Manuela Colafigli; Manuela Colatigli; Paola Cattani; Carmen Pinnetti; Carmen Pannetti; Alessandra Bacarelli; Mattia Prosperi; Giovanni Fadda; Roberto Cauda; Andrea De Luca
Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.
Antiviral therapy 2007;12(5):835-9.
2007: Simona Di Giambenedetto; Alessanra Bacarelli; Carmen Pinnetti; Manuela Colafigli; Mattia Prosperi; Giorgio Gatti; Roberto Cauda; Andrea De Luca
Genotypic resistance to lopinavir and fosamprenavir with or without ritonavir of clinical isolates from patients failing protease inhibitors-containing HAART regimens: prevalence and predictors.
Scandinavian journal of infectious diseases 2007;39(9):813-8.
2006: Alessandro Cozzi-Lepri; Andrea De Luca; Andrew N Phillips; Marco Bongiovanni; Simona Di Giambenedetto; Maurizio Mena; Maria Cristina Moioli; Massimo Arlotti; Laura Sighinolfi; Pasquale Narciso; Miriam Lichtner; Roberto Cauda; Antonella d'Arminio Monforte
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.
The Journal of infectious diseases 2006;194(1):20-8.
2006: G Carosi; C Torti; M Andreoni; G Angarano; A Antinori; S Bonora; M Borderi; A Castagna; F Castelli; R Cauda; F Chiodo; A D'arminio-Monforte; Andrea De Luca; G Di Perri; Ferdinando Dianzani; G Filice; M Galli; A Lazzarin; Franco Maggiolo; R Maserati; Francesco Mazzotta; M Moroni; C F Perno; V Vullo
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005).
The Journal of antimicrobial chemotherapy 2006;57(6):1055-64.
2006: Andrea De Luca; Simona Di Giambenedetto; Laura Romano; Angela Gonnelli; Paola Corsi; Marco Baldari; Massimo Di Pietro; Stefano Menzo; Daniela Francisci; Paolo Almi; Maurizio Zazzi
Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy.
The Journal of infectious diseases 2006;193(9):1219-22.
2006: Carlo Torti; Maria Cristina Uccelli; Eugenia Quiros-Roldan; Franco Gargiulo; Valeria Tirelli; Giuseppe Lapadula; Mario Regazzi; Piera Pierotti; Carmine Tinelli; Andrea De Luca; Andrea Patroni; Nino Manca; Giampiero Carosi
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitors.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;35(4):414-9.
2006: David A van de Vijver; Annemarie M J Wensing; Gioacchino Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Marie-Laure Chaix; Dominique Costagliola; Andrea De Luca; Inge Derdelinckx; Zehava Grossman; Osamah Hamouda; Angelos Hatzakis; Robert Hemmer; Andy Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh MacRae; Irina Maljkovic; Carmen de Mendoza; Laurence Meyer; Claus Nielsen; Eline L M Op de Coul; Vidar Ormaasen; Dimitrios Paraskevis; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika Salminen; Jean-Claude Schmit; Francois Schneider; Rob Schuurman; Vincent Soriano; Grzegorz Stanczak; Maja Stanojevic; Anne-Mieke Vandamme; Kristel Van Laethem; Michela Violin; Karin Wilbe; Sabine Yerly; Maurizio Zazzi; Charles A B Boucher
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes.
Journal of acquired immune deficiency syndromes (1999) 2006;41(3):352-60.
2006: Andrea De Luca; Alessandro Cozzi-Lepri; Andrea Antinori; Mauro Zaccarelli; Marco Bongiovanni; Simona Di Giambenedetto; Patrizia Marconi; Paola Cicconi; Francesco Resta; Benvenuto Grisorio; Maria Ciardi; Roberto Cauda; Antonella d'Arminio Monforte
Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparison.
Antiviral therapy 2006;11(5):609-18.
2006: Massimo Puoti; Alessandro Cozzi-Lepri; Giuseppe Paraninfo; Claudio Arici; Nina Friis Moller; Jens D Lundgren; bruno ledergerber; Martin Rickenbach; Ignacio Suarez-Lozano; Myriam Garrido; François Dabis; Maria Winnock; Laura Milazzo; Anne Gervais; Francois Raffi; John Gill; Jürgen Rockstroh; Nazifa Ourishi; Cristina Mussini; Antonella Castagna; Andrea De Luca; Antonella d'Arminio Monforte
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis.
Antiviral therapy 2006;11(5):567-74.
2006: Andrea De Luca; Simona Di Giambenedetto; Antonella Cingolani; Alessandra Bacarelli; Adriana Ammassari; Roberto Cauda
Three-year clinical outcomes of resistance genotyping and expert advice: extended follow-up of the Argenta trial.
Antiviral therapy 2006;11(3):321-7.
2005: R Cianci; Marcello Pinti; Milena Nasi; S Starnino; Giovanni Cammarota; Luca Miele; Andrea De Luca; R Cauda; F Raducci; Antonio Grieco; Gian Ludovico Rapaccini; Giovanni Gasbarrini; A Cossarizza; Franco Pandolfi
Impairment of recent thymic emigrants in HCV infection.
International journal of immunopathology and pharmacology 2005;18(4):723-8.
2005: Annemarie M J Wensing; David A van de Vijver; Gioacchino Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Maire-Laure Chaix; Dominique Costagliola; Andrea De Luca; Inge Derdelinckx; Zehava Grossman; Osamah Hamouda; Angelos Hatzakis; Robert Hemmer; Andy Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh MacRae; Irina Maljkovic; Carmen de Mendoza; Laurence Meyer; Claus Nielsen; Eline L Op de Coul; Vidar Ormaasen; Dimitrios Paraskevis; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika Salminen; Jean-Claude Schmit; Francois Schneider; Rob Schuurman; Vincent Soriano; Grzegorz Stanczak; Maja Stanojevic; Anne-Mieke Vandamme; Kristel Van Laethem; Michela Violin; Karin Wilbe; Sabine Yerly; Maurizio Zazzi; Charles A Boucher
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.
The Journal of infectious diseases 2005;192(6):958-66.
2005: Giorgio Antonucci; Alessandro Cozzi-Lepri; Enrico Girardi; Maria Rosaria Capobianchi; Andrea De Luca; Antonella d'Arminio Monforte
Effect of hepatitis C virus genotype on CD4+ T cell count in a cohort of antiretroviral-naive HIV-1-infected individuals.
The Journal of infectious diseases 2005;192(4):703-4; author reply 704-5.
2005: Angela Marzocchetti; Simona Di Giambenedetto; Antonella Cingolani; Adriana Ammassari; Roberto Cauda; Andrea De Luca
Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy.
Journal of clinical microbiology 2005;43(8):4175-7.
2005: Giampiero Carosi; Massimo Puoti; Giovanni Antonucci; Andrea De Luca; Renato Maserati; Carlo Torti; Paolo Bonfanti; Stefano Bonora; RAFFAELE BRUNO; Giovanni B Gaeta; Andrea Antinori; Antonella d'Arminio Monforte; Anna Orani; evangelista sagnelli; Antonietta Cargnel; Roberto Cauda; Francesco Mazzotta; Giuseppe Pastore; Fredy Suter; Vincenzo Vullo
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop.
AIDS reviews 2005;7(3):161-7.
2005: Carlo Torti; Eugenia Quiros-Roldan; Mario Regazzi; Andrea De Luca; Francesco Mazzotta; Andrea Antinori; Nicoletta Ladisa; Valeria Micheli; Anna Orani; Andrea Patroni; Paola Villani; Sergio Lo Caputo; Francesca Moretti; Simona Di Giambenedetto; Filippo Castelnuovo; Paolo Maggi; Carmine Tinelli; Giampiero Carosi
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(12):1828-36.
2005: Giorgio Antonucci; Enrico Girardi; Alessandro Cozzi-Lepri; Maria Rosaria Capobianchi; Andrea De Luca; Massimo Puoti; Enzo Petrelli; Giuseppe Carnevale; Giuliano Rizzardini; Paolo Antonio Grossi; Paolo Viganò; Maria Cristina Moioli; Fabrizio Carletti; Mariacarmela Solmone; Giuseppe Ippolito; Antonella d'Arminio Monforte
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(12):e101-9.
2005: Antonella d'Arminio Monforte; Alessandro Cozzi-Lepri; Andrew Phillips; Andrea De Luca; Rita Murri; Cristina Mussini; Paolo Grossi; Andrea Galli; Tiziano Zauli; Maria Montroni; Paolo Tundo; Mauro Moroni
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients.
Journal of acquired immune deficiency syndromes (1999) 2005;38(4):407-16.
2005: Cristina Mussini; Andrea Bedini; Vanni Borghi; Giovanni Guaraldi; Roberto Esposito; Enrico Barchi; Reggio Enilia; Alessandro Cozzi-Lepri; Andrew N Philips; Patrizia Ortolani; Göran Bratt; Lars E Eriksson; Laura Sighinolfi; Andrea Cossarizza; Antonella d'Arminio Monforte; Andrea De Luca; Simona Di Giambenedetto; Andrea Antinori
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.
AIDS (London, England) 2005;19(3):287-94.
2004: Simona Di Giambenedetto; G Vago; A Pompucci; Giancarlo Scoppettuolo; Antonella Cingolani; Angela Marzocchetti; Mario Tumbarello; Roberto Cauda; Andrea De Luca
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?
Neurology 2004;63(12):2452-3.
2004: Anne-Mieke Vandamme; Anders Sönnerborg; M Ait-Khaled; J Albert; B Asjo; Lee Bacheler; D Banhegyi; C Boucher; F Brun-Vézinet; R Camacho; P Clevenbergh; N Clumeck; N Dedes; Andrea De Luca; H W Doerr; J L Faudon; G Gatti; J Gerstoft; W W Hall; A Hatzakis; N Hellmann; A Horban; J D Lundgren; D Kempf; M Miller; V Miller; T W Myers; C Nielsen; M Opravil; L Palmisano; C F Perno; A Phillips; D Pillay; T Pumarola; L Ruiz; M Salminen; J Schapiro; B Schmidt; Jean-Claude Schmit; R Schuurman; E Shulse; V Soriano; S Staszewski; STEFANO VELLA; M Youle; R Ziermann; L Perrin
Updated European recommendations for the clinical use of HIV drug resistance testing.
Antiviral therapy 2004;9(6):829-48.
2004: Rainer Ziermann; Linda Celis; Inge Derdelinckx; Christine Lambert; Jürgen Veeck; Maria Gabriella Rizzo; Bart Vanderborght; Georges Zissis; Nathan Clumeck; Katrien Fransen; Dolores Vaira; David Hendricks; Kristel Van Laethem; Anne-Mieke Vandamme; Jean-Claude Schmit; Heribert Knechten; Andrea De Luca; joost louwagie; Pascale Segers; Kristel De Boeck; Hans Pottel; Annelies De Brauwer; Frank Hulstaert
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31 Suppl 1():S7-15.
2004: Carlo Torti; Eugenia Quiros-Roldan; Valeria Tirelli; M Regazzi-Bonora; Francesca Moretti; Piera Pierotti; Anna Orani; Paolo Maggi; Antonietta Cargnel; Andrea Patroni; Andrea De Luca; Giampiero Carosi
Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patients.
AIDS patient care and STDs 2004;18(11):629-34.
2004: Rita Murri; Adriana Ammassari; Maria Paola Trotta; Andrea De Luca; Sara Melzi; Cristina Minardi; Mauro Zaccarelli; Patrizia Rellecati; Paola Santopadre; Fabrizio Soscia; Antonio Scasso; Valerio Tozzi; Maria Ciardi; Gian Carlo Orofino; Pasquale Noto; Antonella d'Arminio Monforte; Andrea Antinori; Albert W Wu
Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.
Journal of general internal medicine 2004;19(11):1104-10.
2004: Andrea De Luca; Alessandro Cozzi-Lepri; Carlo Federico Perno; Claudia Balotta; Simona Di Giambenedetto; Antonio Poggio; Gabriella Pagano; Giulia Tositti; Rita Piscopo; Antonio Del Forno; Francesco Chiodo; Giacomo Magnani; Antonella d'Arminio Monforte
Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems.
Antiviral therapy 2004;9(5):743-52.
2004: Andrea De Luca; Simona Di Giambenedetto
Triple-nucleoside regimens versus efavirenz.
The New England journal of medicine 2004;351(7):717-9; author reply 717-9.
2004: Andrea De Luca; Marilena Vendittelli; Francesco Baldini; Simona Di Giambenedetto; Maria Paola Trotta; Antonella Cingolani; Alessandra Bacarelli; Caterina Gori; Carlo Federico Perno; Andrea Antinori; Giovanni Ulivi
Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.
Antiviral therapy 2004;9(4):583-93.
2004: Andrea De Luca; Simona Di Giambenedetto; Antonella Cingolani; Adriana Ammassari; Giuseppe Marasca; Mario Tumbarello; Massimo Fantoni; Enrica Tamburrini; Roberto Cauda
Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients.
AIDS (London, England) 2004;18(11):1602-4.
2004: Simona Di Giambenedetto; Francesco Baldini; Antonella Cingolani; Enrica Tamburrini; Roberto Cauda; Andrea De Luca
The influence of hepatitis C virus coinfection on the risk of lipid abnormalities in a cohort of HIV-1-infected patients after initiation of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2004;36(1):641-2.
2004: Andrea De Luca; Francesco Baldini; Antonella Cingolani; Simona Di Giambenedetto; Richard Hoetelmans; Roberto Cauda
Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics.
Journal of acquired immune deficiency syndromes (1999) 2004;35(4):359-66.
2004: Carlo Torti; Eugenia Quiros-Roldan; Mario Regazzi-Bonora; Andrea De Luca; Sergio Lo Caputo; Simona Di Giambenedetto; Andrea Patroni; Paola Villani; Valeria Micheli; Giampiero Carosi
Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations.
Journal of acquired immune deficiency syndromes (1999) 2004;35(3):324-6.
2004: Cristina Mussini; Patrizio Pezzotti; José M Miró; Esteban Martinez; Juan Carlos Lopez Bernaldo de Quiros; Paola Cinque; Vanni Borghi; Andrea Bedini; Pere Domingo; Pedro Cahn; Philippe Bossi; Andrea De Luca; Antonella d'Arminio Monforte; Mark Nelson; Nneka Nwokolo; Silvia Helou; Ricardo Negroni; Gaia Jacchetti; Spinello Antinori; Adriano Lazzarin; Andrea Cossarizza; Roberto Esposito; Andrea Antinori; Judith A Aberg
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(4):565-71.
2003: Andrea De Luca; Carlo Federico Perno
Impact of different HIV resistance interpretation by distinct systems on clinical utility of resistance testing.
Current opinion in infectious diseases 2003;16(6):573-80.
2003: Patrizio Pezzotti; Maria Dorrucci; Alessandra Donisi; Marco Cusini; Giovanni Mazzarello; Andrea De Luca; Bernardino Salassa; Maria Alessandra Ursitti; Massimo Giuliani; Giovanni Rezza
[Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Epidemiologia e prevenzione 2003;27(6):348-55.
2003: Andrea De Luca; Antonella Cingolani; Simona Di Giambenedetto; Maria Paola Trotta; Francesco Baldini; Maria Gabriella Rizzo; Ada Bertoli; Giuseppina Liuzzi; Pasquale Narciso; Rita Murri; Adriana Ammassari; Carlo Federico Perno; Andrea Antinori
Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.
The Journal of infectious diseases 2003;187(12):1934-43.
2003: Maria Paola Trotta; Adriana Ammassari; Alessandro Cozzi-Lepri; Mauro Zaccarelli; Francesco Castelli; Pasquale Narciso; Sara Melzi; Andrea De Luca; Antonella d'Arminio Monforte; Andrea Antinori
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens.
AIDS (London, England) 2003;17(7):1099-102.
2003: Cristina Mussini; Patrizio Pezzotti; Andrea Antinori; Vanni Borghi; Antonella d'Arminio Monforte; Alessandra Govoni; Andrea De Luca; Adriana Ammassari; Nicola Mongiardo; Maria Chiara Cerri; Andrea Bedini; Cristina Beltrami; Maria Alessandra Ursitti; Teresa Bini; Andrea Cossarizza; Roberto Esposito
Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(5):645-51.
2003: Mauro Zaccarelli; Carlo Federico Perno; Federica Forbici; Antonella Cingolani; Giuseppina Liuzzi; Ada Bertoli; Maria Paola Trotta; Maria Concetta Bellocchi; Simona Di Giambenedetto; Valerio Tozzi; Caterina Gori; Roberta D'Arrigo; Patrizio De Longis; Pasquale Noto; Enrico Girardi; Andrea De Luca; Andrea Antinori
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.
Antiviral therapy 2003;8(1):51-6.
2003: Andrea Antinori; Antonella Cingolani; Maria Letizia Giancola; Federica Forbici; Andrea De Luca; Carlo Federico Perno
Clinical implications of HIV-1 drug resistance in the neurological compartment.
Scandinavian journal of infectious diseases. Supplementum 2003;106():41-4.
2003: Andrea De Luca; Andrea Antinori; Simona Di Giambenedetto; Antonella Cingolani; Manuela Colafigli; Carlo Federico Perno; Roberto Cauda
Interpretation systems for genotypic drug resistance of HIV-1.
Scandinavian journal of infectious diseases. Supplementum 2003;106():29-34.
2003: Andrea Antinori; Antonella Cingolani; Patrizia Lorenzini; Maria Letizia Giancola; Ilaria Uccella; Simona Bossolasco; Susanna Grisetti; Francesca Moretti; Beniamino Vigo; Marco Bongiovanni; Bruno Del Grosso; Maria Irene Arcidiacono; Giovanni Carlo Fibbia; Maurizio Mena; Maria Grazia Finazzi; Giovanni Guaraldi; Adriana Ammassari; Antonella d'Arminio Monforte; Paola Cinque; Andrea De Luca
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).
Journal of neurovirology 2003;9 Suppl 1():47-53.
2002: Carlo Federico Perno; Francesca Ceccherini-Silberstein; Andrea De Luca; Alessandro Cozzi-Lepri; Caterina Gori; Antonella Cingolani; Maria Concetta Bellocchi; Maria Paola Trotta; Paola Piano; Federica Forbici; Antonio Scasso; Vincenzo Vullo; Antonella d'Arminio Monforte; Andrea Antinori
Virologic correlates of adherence to antiretroviral medications and therapeutic failure.
Journal of acquired immune deficiency syndromes (1999) 2002;31 Suppl 3():S118-22.
2002: Stefano Aquaro; Patrizia Bagnarelli; Tania Guenci; Andrea De Luca; Massimo Clementi; Emanuela Balestra; Raffaele Caliò; Carlo Federico Perno
Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus.
Journal of medical virology 2002;68(4):479-88.
2002: Andrea De Luca; Roberto Bugarini; Alessandro Cozzi Lepri; Massimo Puoti; Enrico Girardi; Andrea Antinori; Antonio Poggio; Gabriella Pagano; Giulia Tositti; Gian Pietro Cadeo; Antonio Macor; Mario Toti; Antonella d'Arminio Monforte
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
Archives of internal medicine 2002;162(18):2125-32.
2002: Andrea De Luca; BC Ciancio; Dora Larussa; Rita Murri; Antonella Cingolani; Maria Gabriella Rizzo; Maria Letizia Giancola; Adriana Ammassari; L Ortona
Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals.
Neurology 2002;59(3):342-7.
2002: Andrea Antinori; Mauro Zaccarelli; Antonella Cingolani; Federica Forbici; Maria Gabriella Rizzo; Maria Paola Trotta; Simona Di Giambenedetto; Pasquale Narciso; Adriana Ammassari; Enrico Girardi; Andrea De Luca; Carlo Federico Perno
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.
AIDS research and human retroviruses 2002;18(12):835-8.
2002: Kristel Van Laethem; Andrea De Luca; Andrea Antinori; Antonella Cingolani; Carlo Federico Perna; Anne-Mieke Vandamme
A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.
Antiviral therapy 2002;7(2):123-9.
2002: Laura Aian Gillini; Antonella Cingolani; Rita Murri; Andrea De Luca; Simona Di Giambenedetto; Albert W Wu; Roberto Cauda; Richard E Chaisson
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;29(5):546-7.
2002: Federica Sorà; Andrea Antinori; Nicola Piccirillo; Andrea De Luca; Patrizia Chiusolo; Antonella Cingolani; Luca Laurenti; Sergio Rutella; Luigi Ortona; Giuseppe Leone; Simona Sica
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.
Experimental hematology 2002;30(3):279-84.
2002: Antonella Cingolani; Andrea Antinori; Maria Gabriella Rizzo; Rita Murri; Adriana Ammassari; Francesco Baldini; Simona Di Giambenedetto; Roberto Cauda; Andrea De Luca
Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).
AIDS (London, England) 2002;16(3):369-79.
2001: Andrea Antinori; Giuseppina Liuzzi; Antonella Cingolani; Ada Bertoli; Simona Di Giambenedetto; Maria Paola Trotta; Maria Gabriella Rizzo; Enrico Girardi; Andrea De Luca; Carlo Federico Perno
Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy.
AIDS (London, England) 2001;15(17):2325-7.
2001: A de A Monforte; Roberto Bugarini; Patrizio Pezzotti; Andrea De Luca; Andrea Antinori; Cristina Mussini; Gianmarco Vigevani; U Tirelli; R Bruno; F Gritti; Marcello Piazza; S Chigiotti; Antonio Chirianni; Carlo De Stefano; Eligio Pizzigallo; O Perrella; Mauro Moroni
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.
Journal of acquired immune deficiency syndromes (1999) 2001;28(2):114-23.
2001: Andrea Antinori; Francesco Baldini; Enrico Girardi; Antonella Cingolani; Mauro Zaccarelli; Simona Di Giambenedetto; A Barracchini; Patrizio De Longis; Rita Murri; Valerio Tozzi; Adriana Ammassari; Maria Gabriella Rizzo; Giuseppe Ippolito; Andrea De Luca
Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.
AIDS (London, England) 2001;15(12):1579-81.
2001: Andrea Antinori; Antonella Cingolani; Lucia Alba; Adriana Ammassari; D Serraino; BC Ciancio; F Palmieri; Andrea De Luca; L M Larocca; Luigi Ruco; Giuseppe Ippolito; Roberto Cauda
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.
AIDS (London, England) 2001;15(12):1483-91.
2001: Constantin T Yiannoutsos; Andrea De Luca
Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy.
Journal of neurovirology 2001;7(4):369-74.
2001: Andrea De Luca; Maria Letizia Giancola; Adriana Ammassari; Susanna Grisetti; Antonella Cingolani; Dora Larussa; Lucia Alba; Rita Murri; Giuseppe Ippolito; Roberto Cauda; Antonella d'Arminio Monforte; Andrea Antinori
Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study.
Journal of neurovirology 2001;7(4):364-8.
2001: Andrea Antinori; Adriana Ammassari; Maria Letizia Giancola; Antonella Cingolani; Susanna Grisetti; Rita Murri; Lucia Alba; BC Ciancio; Fabio Soldani; Dora Larussa; Giuseppe Ippolito; Andrea De Luca
Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
Journal of neurovirology 2001;7(4):323-8.
2001: Rita Murri; Adriana Ammassari; Andrea De Luca; A Cingolani; P Marconi; Albert W Wu; Andrea Antinori
Self-reported nonadherence with antiretroviral drugs predicts persistent condition.
HIV clinical trials 2001;2(4):323-9.
2001: Costantino Romagnoli; Simonetta Frezza; A Cingolani; Andrea De Luca; M Puopolo; Maria Pia De Carolis; Giovanni Vento; A Antinori; Giuseppe Tortorolo
Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis.
European journal of pediatrics 2001;160(6):345-50.
2001: Alessandro Cozzi-Lepri; Andrew N Phillips; Antonella d'Arminio Monforte; F Castelli; Andrea Antinori; Andrea De Luca; Patrizio Pezzotti; Francesco Alberici; Antonietta Cargnel; P Grima; Rita Piscopo; T Prestileo; G Scalise; M Vigevani; Mauro Moroni
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study.
AIDS (London, England) 2001;15(8):983-90.
2001: Rita Murri; Adriana Ammassari; P Pezzotti; Antonella Cingolani; Andrea De Luca; Federico Pallavicini; Rita Luciana Grillo; Andrea Antinori
Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial.
Journal of acquired immune deficiency syndromes (1999) 2001;27(1):49-55.
2001: Enrico Girardi; F Palmieri; Antonella Cingolani; Adriana Ammassari; Nicola Petrosillo; Laura Aian Gillini; D Zinzi; Andrea De Luca; Andrea Antinori; Giuseppe Ippolito
Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2001;26(4):326-31.
2000: Antonella Cingolani; Roberta Gastaldi; Lucia Fassone; Francesco Pierconti; Maria Letizia Giancola; Maurizio Martini; Andrea De Luca; Adriana Ammassari; C Mazzone; Edoardo Pescarmona; Gianluca Gaidano; Luigi Maria Larocca; Andrea Antinori
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3325-30.
2000: Andrea De Luca; Maria Letizia Giancola; Adriana Ammassari; Susanna Grisetti; M G Paglia; M Gentile; Antonella Cingolani; Rita Murri; Giuseppina Liuzzi; Antonella d'Arminio Monforte; Andrea Antinori
The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.
The Journal of infectious diseases 2000;182(4):1077-83.
2000: Andrea De Luca; Maria Letizia Giancola; Adriana Ammassari; Susanna Grisetti; Antonella Cingolani; M G Paglia; Alessandra Govoni; Rita Murri; Letizia Testa; Antonella d'Arminio Monforte; Andrea Antinori
Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
AIDS (London, England) 2000;14(14):F117-21.
2000: Giovanni Rezza; Alessandro Cozzi Lepri; Antonella d'Arminio Monforte; Patrizio Pezzotti; F Castelli; Ferdinando Dianzani; Adriano Lazzarin; Andrea De Luca; Massimo Arlotti; Francesco Leoncini; Paolo E Manconi; Giuliano Rizzardini; L Minoli; Antonio Poggio; Giuseppe Ippolito; Andrew N Phillips; Mauro Moroni
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):56-62.
2000: Francesco Baldini; Simona Di Giambenedetto; Antonella Cingolani; Rita Murri; Adriana Ammassari; Andrea De Luca
Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
AIDS (London, England) 2000;14(11):1660-2.
2000: Andrea De Luca; Francesco Baldini; Antonella Cingolani; Simona Di Giambenedetto; Mauro Zaccarelli; Valerio Tozzi; Adriana Ammassari; Rita Murri; Andrea Antinori
Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study.
AIDS (London, England) 2000;14(11):1655-6.
2000: Andrea De Luca; Maria Letizia Giancola; Antonella Cingolani; Adriana Ammassari; Rita Murri; Andrea Antinori
Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
AIDS research and human retroviruses 2000;16(9):835-43.
2000: Rita Murri; Adriana Ammassari; K Gallicano; Andrea De Luca; Antonella Cingolani; D Jacobson; Albert W Wu; Andrea Antinori
Patient-reported nonadherence to HAART is related to protease inhibitor levels.
Journal of acquired immune deficiency syndromes (1999) 2000;24(2):123-8.
2000: Cristina Mussini; Patrizio Pezzotti; Alessandra Govoni; Vanni Borghi; Andrea Antinori; Antonella d'Arminio Monforte; Andrea De Luca; Nicola Mongiardo; Maria Chiara Cerri; F Chiodo; Ercole Concia; L Bonazzi; Mauro Moroni; L Ortona; Roberto Esposito; Andrea Cossarizza; B De Rienzo
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
The Journal of infectious diseases 2000;181(5):1635-42.
2000: Antonella d'Arminio Monforte; Alessandro Cozzi Lepri; Giovanni Rezza; Patrizio Pezzotti; Andrea Antinori; Andrew N Phillips; Gioacchino Angarano; Vincenzo Colangeli; Andrea De Luca; Giuseppe Ippolito; L Caggese; F Soscia; G Filice; F Gritti; P Narciso; U Tirelli; Mauro Moroni
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients.
AIDS (London, England) 2000;14(5):499-507.
1999: Giovanni Rezza; Maria Dorrucci; Massimo Andreoni; Carla Arpino; Andrea De Luca; paolo monini; Emanuele Nicastri; MB Alliegro; Patrizio Pezzotti; Barbara Ensoli
Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study.
Neurology 1999;53(9):2032-6.
1999: Rita Murri; Adriana Ammassari; Andrea De Luca; A Cingolani; A Antinori
Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patients.
Lancet 1999;353(9168):1974.
1999: Antonella Cingolani; Andrea Antinori; maurizio Sanguinetti; Laura Aian Gillini; Andrea De Luca; Brunella Posteraro; Fausta Ardito; Giovanni Fadda; L Ortona
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy.
The Journal of infectious diseases 1999;179(4):1025-9.
1999: Andrea De Luca; Massimo Fantoni; Tommaso Tartaglione; Andrea Antinori
Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy.
Neurology 1999;52(4):891-2.
1999: Andrea De Luca; Maria Letizia Giancola; Antonella Cingolani; Adriana Ammassari; Laura Aian Gillini; Rita Murri; Andrea Antinori
Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(3):624-8.
1999: Rita Murri; A Ammassari; Andrea De Luca; A Cingolani; A Antinori; L Ortona
Use of antiretroviral therapy by intravenous drug users with HIV.
JAMA : the journal of the American Medical Association 1999;281(8):700-1.
1999: Andrea Antinori; G De Rossi; Adriana Ammassari; Antonella Cingolani; Rita Murri; Daniela Di Giuda; Andrea De Luca; Francesco Pierconti; Tommaso Tartaglione; Massimo Scerrati; Luigi Maria Larocca; L Ortona
Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):554-60.
1999: Andrea Antinori; Antonella Cingolani; Andrea De Luca; Gianluca Gaidano; Adriana Ammassari; Luigi Maria Larocca; L Ortona
Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma.
Annals of neurology 1999;45(2):259-61.
1998: Andrea De Luca; Adriana Ammassari; Antonella Cingolani; Maria Letizia Giancola; Andrea Antinori
Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
AIDS (London, England) 1998;12(14):1937-8.
1998: Adriana Ammassari; Giancarlo Scoppettuolo; Rita Murri; P Pezzotti; Antonella Cingolani; Cosmo Del Borgo; Andrea De Luca; Andrea Antinori; L Ortona
Changing disease patterns in focal brain lesion-causing disorders in AIDS.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;18(4):365-71.
1998: Andrea De Luca; Rita Murri; F Damiano; Adriana Ammassari; Andrea Antinori
"Buffalo hump" in HIV-1 infection.
Lancet 1998;352(9124):320.
1998: Federico Pallavicini; Adriana Ammassari; Andrea De Luca; C F Perno; A Cenci; Antonella Cingolani; Rita Luciana Grillo; R Proietti; L Ortona
HIV-1 infection and progressive multifocal leukoencephalopathy in a person without detectable HIV antibodies.
AIDS (London, England) 1998;12(10):1251-3.
1998: Andrea De Luca; A Antinori; L Ortona
Antiretroviral therapy and improving AIDS survival.
JAMA : the journal of the American Medical Association 1998;279(23):1874-5.
1998: maurizio Sanguinetti; Brunella Posteraro; Fausta Ardito; Stefania Zanetti; Antonella Cingolani; Leonardo A Sechi; Andrea De Luca; L Ortona; Giovanni Fadda
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media.
Journal of clinical microbiology 1998;36(6):1530-3.
1998: Antonella Cingolani; Andrea De Luca; Luigi Maria Larocca; Adriana Ammassari; Massimo Scerrati; Andrea Antinori; L Ortona
Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma.
Journal of the National Cancer Institute 1998;90(5):364-9.
1998: Rodolfo Capizzi; G Marasca; Andrea De Luca; E Tacconelli; R Cauda; Maurizio Rotoli
Pemphigus vulgaris in a human-immunodeficiency-virus-infected patient.
Dermatology (Basel, Switzerland) 1998;197(1):97-8.
1998: L Ortona; Andrea De Luca
BCG and prospects for new vaccines against tuberculosis.
Rays 1998;23(1):225-30.
1998: L Ortona; Andrea De Luca
Epidemiology of multidrug-resistant tuberculosis.
Rays 1998;23(1):15-8.
1997: Rita Murri; Adriana Ammassari; Massimo Fantoni; Giancarlo Scoppettuolo; Antonella Cingolani; Andrea De Luca; F Damiano; Andrea Antinori
Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(5):350-6.
1997: Andrea Antinori; Adriana Ammassari; Andrea De Luca; Antonella Cingolani; Rita Murri; Giancarlo Scoppettuolo; M Fortini; Tommaso Tartaglione; Luigi Maria Larocca; G Zannoni; P Cattani; Rita Luciana Grillo; R Roselli; Maurizio Iacoangeli; Massimo Scerrati; L Ortona
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.
Neurology 1997;48(3):687-94.
1996: Antonella Cingolani; Andrea De Luca; Adriana Ammassari; Rita Murri; A Linzalone; Rita Luciana Grillo; Andrea Antinori
PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions.
Journal of medical microbiology 1996;45(6):472-6.
1996: Antonella Cingolani; Andrea De Luca; Adriana Ammassari; Rita Murri; A Linzalone; Rita Luciana Grillo; Maria Letizia Giancola; Andrea Antinori
Detection of T.gondii-DNA by PCR in AIDS-related toxoplasmic encephalitis.
The Journal of eukaryotic microbiology 1996;43(5):118S-119S.
1996: Enrica Tamburrini; P Mencarini; Elena Visconti; M Zolfo; Andrea De Luca; Alessandra Siracusano; Elena Ortona; Paola Margutti; Ann E Wakefield
Comparison of two PCR methods for detection of Pneumocystis carinii in bronchoalveolar lavage fluid.
The Journal of eukaryotic microbiology 1996;43(5):20S.
1996: Enrica Tamburrini; P Mencarini; Elena Visconti; M Zolfo; Andrea De Luca; Alessandra Siracusano; Elena Ortona; Paola Margutti; Ann E Wakefield; S E Peters; C M Denis; Eduardo Dei-Cas
Detection of Pneumocystis carinii DNA in HIV patients with P. carinii pneumonia (PCP) and in animal models.
The Journal of eukaryotic microbiology 1996;43(5):18S-19S.
1996: Enrica Tamburrini; P Mencarini; Elena Visconti; Andrea De Luca; M Zolfo; Alessandra Siracusano; Elena Ortona; Rita Murri; Andrea Antinori
Imbalance between Pneumocystis carinii cysts and trophozoites in bronchoalveolar lavage fluid from patients with pneumocystosis receiving prophylaxis.
Journal of medical microbiology 1996;45(2):146-8.
1996: Elena Ortona; Paola Margutti; Andrea De Luca; S E Peters; Ann E Wakefield; Enrica Tamburrini; P Mencarini; Elena Visconti; Alessandra Siracusano
Non specific PCR products using rat-derived Pneumocystis carinii dihydrofolate reductase gene-specific primers in DNA amplification of human respiratory samples.
Molecular and cellular probes 1996;10(3):187-90.
1996: Enrica Tamburrini; P Mencarini; Elena Visconti; M Zolfo; Andrea De Luca; Alessandra Siracusano; Elena Ortona; Ann E Wakefield
Detection of Pneumocystis carinii DNA in blood by PCR is not of value for diagnosis of P. carinii pneumonia.
Journal of clinical microbiology 1996;34(6):1586-8.
1996: Andrea De Luca; Antonella Cingolani; A Linzalone; Adriana Ammassari; Rita Murri; Maria Letizia Giancola; G Maiuro; Andrea Antinori
Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy.
Journal of clinical microbiology 1996;34(5):1343-6.
1996: Marina Viora; Andrea De Luca; Antonella D'Ambrosio; A Antinori; Elena Ortona
In vitro and in vivo immunomodulatory effects of anti-Pneumocystis carinii drugs.
Antimicrobial agents and chemotherapy 1996;40(5):1294-7.
1996: Adriana Ammassari; Rita Murri; Antonella Cingolani; Andrea De Luca; Andrea Antinori
AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment.
Current topics in microbiology and immunology 1996;219():209-22.
1996: G Villa; A Solida; E Moro; M Tavolozza; A Antinori; Andrea De Luca; Rita Murri; E Tamburrini
Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study.
European neurology 1996;36(3):125-33.
1996: Emma C Guerra; G Ricci; Marta Carlesimo; A R Varani; O Pontesilli; Enrico Scala; Ivano Mezzaroma; Franco Pandolfi; A Antinori; Andrea De Luca; Rita Murri; Adriana Ammassari; L Ortona; Fernando Aiuti
Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn).
Antibiotics and chemotherapy 1996;48():147-54.
1995: Andrea Antinori; Rita Murri; Adriana Ammassari; Andrea De Luca; A Linzalone; Antonella Cingolani; F Damiano; G Maiuro; J Vecchiet; Giancarlo Scoppettuolo
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
AIDS (London, England) 1995;9(12):1343-50.
1995: Andrea De Luca; Enrica Tamburrini; Elena Ortona; P Mencarini; Paola Margutti; Andrea Antinori; Elena Visconti; Alessandra Siracusano
Variable efficiency of three primer pairs for the diagnosis of Pneumocystis carinii pneumonia by the polymerase chain reaction.
Molecular and cellular probes 1995;9(5):333-40.
1995: Andrea De Luca; Andrea Antinori; Antonella Cingolani; Luigi Maria Larocca; A Linzalone; Adriana Ammassari; Massimo Scerrati; R Roselli; E Tamburrini; L Ortona
Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
British journal of haematology 1995;90(4):844-9.
1995: Elena Ortona; Paola Margutti; Andrea De Luca; Enrica Tamburrini; Elena Visconti; Alessandra Siracusano
Genetic variability in different Pneumocystis isolates from man and rats.
The new microbiologica 1995;18(3):335-40.
1995: A Antinori; A Antinori; Adriana Ammassari; Riccardo Masetti; Andrea De Luca; Rita Murri; E Tamburrini; Paolo Magistrelli
Presumptive clinical criteria versus endoscopy in the diagnosis of Candida esophagitis at various HIV-1 disease stages.
Endoscopy 1995;27(5):371-6.
1995: Andrea Antinori; L Pagano; Andrea De Luca; R Marra; P Mencarini; Enrica Tamburrini
Role of Pneumocystis carinii DNA amplification by PCR on the diagnosis of Pneumocystis carinii pneumonia in patients with haematologic malignant diseases: report of four cases.
Acta haematologica 1995;94(3):163-6.
1994: Andrea De Luca; Elena Ortona; Paola Margutti; Elena Visconti; Enrica Tamburrini; Alessandra Siracusano
Different amplification efficiency and nucleotide sequence variation in various Pneumocystis isolates from humans and rats.
The Journal of eukaryotic microbiology 1994;41(5):85S.
1993: Enrica Tamburrini; P Mencarini; Andrea De Luca; Andrea Antinori; Elena Visconti; Adriana Ammassari; L Ortona; Elena Ortona; Alessandra Siracusano; G Vicari
Simple and rapid two-step polymerase chain reaction for diagnosis of Pneumocystis carinii infection.
Journal of clinical microbiology 1993;31(10):2788-9.
1993: Andrea De Luca; Luciana Teofili; Andrea Antinori; Stefania Iovino; P Mencarini; Elena Visconti; E Tamburrini; G Leone; L Ortona
Haemopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis.
British journal of haematology 1993;85(1):20-4.
1993: Enrica Tamburrini; P Mencarini; Andrea De Luca; G Maiuro; G Ventura; Andrea Antinori; Adriana Ammassari; Elena Visconti; L Ortona; Alessandra Siracusano
Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens.
Journal of medical microbiology 1993;38(6):449-53.
1992: Andrea Antinori; Enrica Tamburrini; G Pagliari; G Maiuro; Federico Pallavicini; Andrea De Luca; L Ortona
Alveolar macrophages from AIDS patients spontaneously produce elevated levels of TNF-alpha in vitro.
Allergologia et immunopathologia 1992;20(6):249-54.
1992: A Antinori; Rita Murri; Enrica Tamburrini; Andrea De Luca; L Ortona
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia.
Lancet 1992;340(8822):788.
1991: P Mencarini; Andrea De Luca; Andrea Antinori; G Maiuro; G Spedini; C Bailly; Enrica Tamburrini
Prevalence of anti-HCV antibodies in Cameroon.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1991;85(5):654-5.
1991: Enrica Tamburrini; Andrea De Luca; G Ventura; G Maiuro; Alessandra Siracusano; Elena Ortona; Andrea Antinori
Pneumocystis carinii stimulates in vitro production of tumor necrosis factor-alpha by human macrophages.
Medical microbiology and immunology 1991;180(1):15-20.
1991: P Mencarini; Enrica Tamburrini; Andrea Antinori; G Zannoni; Andrea De Luca; A Capelli; L Ortona
[Determination of HIV-RNA using in situ hybridization on myocardial tissue. Role of HIV in cardiomyopathy in AIDS].
Bollettino dell'Istituto sieroterapico milanese 1991;70(1-2):457-65.
1990: Enrica Tamburrini; Andrea De Luca; G Ventura; G Maiuro; Alessandra Siracusano; Elena Ortona; Andrea Antinori
[Macrophages from healthy adults release TNF-alpha after exposure to Pneumocystis carinii of murine origin. Preliminary study].
Medicina (Florence, Italy) 1990;10(4):393-4.